Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis-Reference-Cited by-同舟云学术

Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis

Published:2023 Issue:7 Volume:11 Page:2478-2485
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Li Yawei¹,Zhang Wei¹,Shi Naiyuan¹,Li Wenqing¹,Bi Junxia¹,Feng Xianmin¹^ORCID,Shi Nianqiu¹,Zhu Wenhe¹^ORCID,Xie Zhigang²^ORCID

Affiliation:

1. Jilin Medical University, Jilin, 132013, P. R. China

2. State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China

Abstract

This work reveals the rationale of developing pure nanodrugs via the self-assembly of dihydroartemisinin for cancer therapy and the mechanism of action.

Funder

National Natural Science Foundation of China

Jilin Scientific and Technological Development Program

Education Department of Jilin Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/BM/D2BM01949C

Reference52 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries